Intravesically administered BCG alternating with IFN‐α vs intravesically administered BCG alone
Time to recurrence · patients with non‐muscle invasive bladder cancer
Intravesically administered BCG alternating with IFN‐α may leads to higher time‐to‐recurrence compared with intravesically administered BCG alone (low certainty).
1 finding from 1 review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes onlyHR 2.86 [1.98, 4.13]1 study · 205 participantsLow